There are 9 item(s) tagged with the keyword "340b drug pricing program".
Displaying: 1 - 9 of 9
Council President Katy Johnson notes the first batch of guidance released by the administration and explains how the Council is working to ensure that these accounts are user-friendly for employers and employees.
Examining and addressing the factors fueling higher hospital costs is essential to lowering health care costs for all Americans.
The Council is urging Congress to pass bipartisan policies that lower health costs for employers and working families by addressing the root causes of rising health care costs.
Lawmakers can lower health care costs by restoring the 340B drug pricing program to its original intent.
In this episode, Council President Katy Johnson describes how several recent developments have put a spotlight on 340B reform.
Council applauds introduction of 340B ACCESS Act as CBO report underscores need for reform
The exponential growth of the 340B drug pricing program is driving up costs for employers, working families, taxpayers.
Cassidy's report is consistent with the Council's recent study showing how the drug pricing program is driving up health care costs for employers, working families and taxpayers.
The exponential growth of the 340B drug pricing program is driving up costs for employers, working families, taxpayers.
Displaying: 1 - 9 of 9